Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22355
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Breast Neoplasms/*drug therapy/mortality/pathology/surgery,Chemotherapy, Adjuvant,Confidence Intervals,Disease Progression,Disease-Free Survival,Drug Administration Schedule,Epirubicin/administration & dosage/adverse effects,Female,Greece,Humans,Middle Aged,Neoplasm Metastasis,Paclitaxel/administration & dosage/adverse effects,Receptors, Estrogen/analysis,Receptors, Progesterone/analysis,Survival Analysis
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/22355
ISSN: 0735-7907
Link: http://www.ncbi.nlm.nih.gov/pubmed/11296618
http://informahealthcare.com/doi/abs/10.1081/CNV-100000148
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons